Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q2 EPS of ($0.39), $0.04 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.